Articles | In-Depth Analysis | Research/ Review Paper

Chromatography Resin Market worth $4.1 billion by 2028 – At a CAGR of 8.2%.

Published: October 3, 2023

The According to a market research report, the “Chromatography Resin Market by type (Natural, Synthetic, Inorganic Media), Technique (Ion Exchange, Affinity, Hydrophobic Interaction, Size Exclusion, Mixed Mode), Application (Pharmaceutical & Biotechnology, FnB), Region – Global Forecasts to 2028″, size is projected to reach USD 4.1 billion by 2028 from USD  2.8 billion in 2023, at a CAGR of 8.2%. The growth of the chromatography resins market is encouraged by the huge demand from the pharmaceuticals and biotechnology industries. Chromatography is a process of separating components of a mixture. The process starts with the mixture being dissolved in a substance called the mobile phase and further being carried through a second substance termed the stationary phase. Increasing demand for biosimilars is driving the market for chromatography resin.

Download PDF Brochure:


  • 259 Market data Tables
  • 58 Figures
  • 284 Pages and in-depth TOC on “Chromatography Resin Market – Global Forecast to 2028” 

This report also provides a comprehensive analysis of the companies listed below:

The chromatography resin market is dominated by key players such as Bio-Rad Laboratories Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Tosoh Corporation (Japan), Bio-Works Technologies AB (Sweden), Avantor Performance Materials, Inc. (US), Mitsubishi Chemical Corporation (Japan), among others. These players have a strong position in the global chromatography resin market as well as a strong distribution network across the globe.

Merger & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the chromatography resin market.

Recent Developments in Chromatography Resin Market Industry

  • In April 2020, Bio-Rad Laboratories, Inc. recently introduced its SARS-CoV-2 Total Ab test, a kit designed for blood-based immunoassays. This test aids in the identification of antibodies developed against SARS-CoV-2, the virus responsible for COVID-19. It has the capability to detect IgG, IgM, and IgA antibodies, offering a more comprehensive approach compared to tests that target a single immunoglobulin. The utilization of multiple immunoglobulins enhances the sensitivity of the assay, providing more accurate results in determining the presence of antibodies against SARS-CoV-2.
  • In October 2021, Tosoh Bioscience LLC, a subsidiary of Tosoh Corporation, successfully finalized the acquisition of Semba Biosciences. Semba Biosciences is a renowned pioneer in the development of multi-column chromatography (MCC) instrumentation and technology, specifically for the downstream purification of biologics. This strategic acquisition has enabled Tosoh Biosciences to enhance and broaden its chromatography resin-related business.
  • In March 2020, The acquisition of General Electric Company’s life sciences division’s Biopharma business by Danaher Corporation was successfully concluded. Following the acquisition, the business has been renamed Cytiva and will operate independently as a standalone company within Danaher’s life sciences segment.

Request Sample Pages:

Based on type, Natural polymer was the largest segment of the chromatography resin market, in terms of value, in 2022, while the synthetic resins segment is projected to register the highest CAGR between 2023 and 2028. Base oil is the primary material used for blending lubricants. The high demand for natural polymers is mainly due to their hydrophilic nature, as they have a large number of hydroxyl groups in their structure.

Based on application, the pharmaceutical and biotechnology application held the largest share of the market and is projected to see the fastest rate of value growth between 2023 and 2028. This is a result of the biotechnology industry’s increased R&D spending. R&D in therapeutic fields like cancer, HIV/AIDS, and immune disorders, as well as technology advancements, are growing. The growing number of drug discovery and clinical trial projects, the patent expiration of blockbuster drugs and biomolecules, and increasing pharmaceutical and biotechnology companies’ focus on expanding their product pipelines are some of the major factors boosting this market’s growth in biotechnology research.

In 2022, the chromatography resin market was dominated by North America. The region’s demand for chromatography resin is being driven by the active R&D efforts in therapeutic monoclonal antibodies in oncology and other therapeutic fields. During the forecast period, the market with the fastest-growing value is projected to be Asia Pacific. The demand for chromatography resin in this region is being driven by rising concerns about food safety as well as growing investments in pharmaceutical and life science research.

Inquire Now

Related Posts